BlackRock’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.9M Buy
8,205,006
+2,892,464
+54% +$15.8M ﹤0.01% 2480
2025
Q1
$33.4M Buy
5,312,542
+1,384,080
+35% +$8.71M ﹤0.01% 2584
2024
Q4
$16.2M Buy
3,928,462
+706,710
+22% +$2.91M ﹤0.01% 3132
2024
Q3
$10.8M Buy
3,221,752
+86,637
+3% +$289K ﹤0.01% 3319
2024
Q2
$9.34M Buy
3,135,115
+759,406
+32% +$2.26M ﹤0.01% 3372
2024
Q1
$8.2M Buy
2,375,709
+55,993
+2% +$193K ﹤0.01% 3396
2023
Q4
$3.11M Buy
2,319,716
+171,453
+8% +$230K ﹤0.01% 3800
2023
Q3
$4.68M Sell
2,148,263
-86,598
-4% -$189K ﹤0.01% 3621
2023
Q2
$5.34M Buy
2,234,861
+2,152,616
+2,617% +$5.14M ﹤0.01% 3626
2023
Q1
$152K Buy
82,245
+1,474
+2% +$2.73K ﹤0.01% 4774
2022
Q4
$156K Buy
80,771
+21,947
+37% +$42.4K ﹤0.01% 4835
2022
Q3
$90K Buy
58,824
+1,330
+2% +$2.04K ﹤0.01% 5118
2022
Q2
$161K Buy
57,494
+24,055
+72% +$67.4K ﹤0.01% 5009
2022
Q1
$73K Sell
33,439
-11,509
-26% -$25.1K ﹤0.01% 5264
2021
Q4
$35K Buy
44,948
+1,049
+2% +$817 ﹤0.01% 5394
2021
Q3
$61K Sell
43,899
-281
-0.6% -$390 ﹤0.01% 5189
2021
Q2
$99K Buy
44,180
+11,786
+36% +$26.4K ﹤0.01% 4981
2021
Q1
$87K Buy
32,394
+9,357
+41% +$25.1K ﹤0.01% 4790
2020
Q4
$56K Buy
23,037
+919
+4% +$2.23K ﹤0.01% 4579
2020
Q3
$89K Sell
22,118
-1,595
-7% -$6.42K ﹤0.01% 4433
2020
Q2
$155K Buy
23,713
+14,641
+161% +$95.7K ﹤0.01% 4328
2020
Q1
$30K Buy
9,072
+1,723
+23% +$5.7K ﹤0.01% 4484
2019
Q4
$28K Buy
7,349
+6,185
+531% +$23.6K ﹤0.01% 4548
2019
Q3
$5K Sell
1,164
-2,320
-67% -$9.97K ﹤0.01% 4733
2019
Q2
$26K Buy
+3,484
New +$26K ﹤0.01% 4595